Villatoro AJ, Fernández V, Claros S, Rico- Llanos GA, Becerra J, Andrades JA. Biomed Res Int. 2015.
Archives de l’auteur : Eric Mairet
28 – Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen A-M, Elgue G, Funke L, et al. STEM CELLS. 2012;30:1565–74.
27 – Scintigraphic evaluation of intra-arterial and intrave- nous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using 99mTc-HMPAO: Regional limb perfusion of stem cells.
Sole A, Spriet M, Galuppo LD, Padgett KA, Borjesson DL, Wisner ER, et al. Equine Veterinary Journal. 2012;44:594–9.
26 – Anti-Inflammatory and Immunomodulatory Activities of Stem Cells.
Peroni JF, Borjesson DL. Veterinary Clinics of North America: Equine Practice. 2011;27:351–62.
25 – A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions.
Centeno CJ, Al-Sayegh H, Freeman MD, Smith J, Murrell WD, Bubnov R. International Orthopaedics. 2016;40:1755– 65.
24 – Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
Kol A, Wood JA, Carrade Holt DD, Gillette JA, Bohannon-Worsley LK, Puchalski SM, et al. Stem Cell Res Ther. 2015;6:73.
23 – Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.
Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. PLoS ONE. 2012;7:e47559.
22 – Transplantation of amniotic membrane-derived multipotent cells ameliorates and delays the progression of chronic kidney disease in cats.
Vidane AS, Pinheiro AO, Casals JB, Passarelli D, Hage M, Bueno RS, et al. Reprod Domest Anim. 2017;52 Suppl 2:316–26.
21 – Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study.
Webb TL,Webb CB. J Feline Med Surg. 2015;17:901–8.
20 – Safety and efficacy of allogeneic adipose tissue-derived mesen- chymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes.
Pérez-Merino EM, Usón-Casaús JM, Zaragoza- Bayle C, Duque-Carrasco J, Mariñas-Pardo L, Hermida-Prieto M, et al. Vet J. 2015b;206:385– 90.
